Gerresheimer AG’s revenue grew 6.7% year-over-year during its third quarter — with adjusted earnings up 2% — as medical plastic systems continued to be a revenue growth driver, especially due to the company’s U.S. inhaler project.
“Our business is pulling ahead as expected: The third quarter went well. We are consequently confirming our revenue guidance for this year,” Rainer Beaujean, speaker of the company’s management board and CFO, said in a news release.
Beaujean also noted that the integration of the recently acquired Sensile Medical and its liquid drug delivery technology is proceeding fully to plan. “Its first product has gained European certification and is now being brought to market by the pharma company concerned.”
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.